Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 3, 2010, Pages 451-457

  Moore, Catrin E ^a   Sengduangphachanh, Amphone ^a   Thaojaikong, Thaksinaporn ^a   Sirisouk, Joy ^a   Foster, Dona ^b   Phetsouvanh, Rattanaphone ^a   McGee, Lesley ^c   Crook, Derrick W ^b   Newton, Paul N ^a   Peacock, Sharon J ^d  

^a MAHOSOT HOSPITAL   (Laos)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT; PRIMER DNA;

ANTIBIOTIC SENSITIVITY; ARTICLE; CEREBROSPINAL FLUID; HUMAN; INVASIVE PNEUMOCOCCAL DISEASE; LAOS; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; CLASSIFICATION; DRUG EFFECT; GENETICS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOGENICITY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; STREPTOCOCCUS INFECTION;

STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; DNA PRIMERS; HUMANS; LAOS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL VACCINES; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 77957045982     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.10-0225     Document Type: Article

References (39)

1. World Health Organization WHO, 2003. WHO-Recommended Standards for Surveillance of Selected Vaccine-Preventable Diseases, Vaccine Assessment and Monitoring Team of the Department of Vaccines and Biologicals. Available at: http://www.who.int/vaccines-documents/DocsPDF06/843.pdf. Accessed May 15, 2009.
2. Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, Farley MM, Jorgensen JH, Lexau CA, Petit S, Reingold A, Schaffner W, Thomas A, Whitney CG, Harrison LH, 2009. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 360: 244-256.
3. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A, 2003. Decline in invasive pneumococcal disease after the introduction of proteinpolysaccharide conjugate vaccine. N Engl J Med 348: 1737-1746. (Pubitemid 36514704)
4. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, Pierce NF, Greenwood BM, Adegbola RA, 2005. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365: 1139-1146. (Pubitemid 40417563)
5. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N, 2003. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349: 1341-1348. (Pubitemid 37186212)
6. Scott JA, 2007. The preventable burden of pneumococcal disease in the developing world. Vaccine 25: 2398-2405. (Pubitemid 46366119)
7. Grijalva CG, Edwards KM, 2006. Promises and challenges of pneumococcal conjugate vaccines for the developing world. Clin Infect Dis 43: 680-682. (Pubitemid 44330727)
8. Lucero MG, Nohynek H, Williams G, Tallo V, Simoes EA, Lupisan S, Sanvictores D, Forsyth S, Puumalainen T, Ugpo J, Lechago M, de Campo M, Abucejo-Ladesma E, Sombrero L, Nissinen A, Soininen A, Ruutu P, Riley I, Makela HP, 2009. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J 28: 455-462.
9. Hausdorff WP, Bryant J, Paradiso PR, Siber GR, 2000. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30: 100-121. (Pubitemid 30067069)
10. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR, 2000. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 30: 122-140. (Pubitemid 30067070)
11. UNICEF, 2007. UNICEF Website Demographics; At a Glance: Lao People's Democratic Republic. Statistics. Available at: http://www.unicef.org/ infobycountry/laopdr-statistics.html. Accessed June 20, 2009.
12. Phetsouvanh R, Phongmany S, Soukaloun D, Rasachak B, Soukhaseum V, Soukhaseum S, Frichithavong K, Khounnorath S, Pengdee B, Phiasakha K, Chu V, Luangxay K, Rattanavong S, Sisouk K, Keolouangkot V, Mayxay M, Ramsay A, Blacksell SD, Campbell J, Martinez-Aussel B, Heuanvongsy M, Bounxouei B, Thammavong C, Syhavong B, Strobel M, Peacock SJ, White NJ, Newton PN, 2006. Causes of community-acquired bacteremia and patterns of antimicrobial resistance in Vientiane, Laos. Am J Trop Med Hyg 75: 978-985. (Pubitemid 351627553)
13. Carvalho Mda G, Tondella ML, McCaustland K, Weidlich L, McGee L, Mayer LW, Steigerwalt A, Whaley M, Facklam RR, Fields B, Carlone G, Ades EW, Dagan R, Sampson JS, 2007. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 45: 2460-2466. (Pubitemid 47295474)
14. Cheeseborough M, 2006. District Laboratory Practice in Tropical Countries. Volume 2. Cambridge, United Kingdom: Cambridge University Press.
15. Austrian R, 1976. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med 43: 699-709. (Pubitemid 8021485)
16. Clinical and Laboratory Standards Institute, 2009. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard, Tenth Edition. Approved Standard M02-A10. Wayne, PA: Clinical and Laboratory Standards Institute.
17. Clinical and Laboratory Standards Institute, 2009. Performance Standards for Antimicrobial Susceptibility Testing. Nineteenth International (Supplement): M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute.
18. Ikejima H, Haranaga S, Takemura H, Kamo T, Takahashi Y, Friedman H, Yamamoto Y, 2001. PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids. Clin Diagn Lab Immunol 8: 499-502. (Pubitemid 32428870)
19. Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB, 2001. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39: 1553-1558. (Pubitemid 32275465)
20. Parry CM, Diep TS, Wain J, Hoa NT, Gainsborough M, Nga D, Davies C, Phu NH, Hien TT, White NJ, Farrar JJ, 2000. Nasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agents. Antimicrob Agents Chemother 44: 484-488. (Pubitemid 30117930)
21. Baggett HC, Peruski LF, Olsen SJ, Thamthitiwat S, Rhodes J, Dejsirilert S, Wongjindanon W, Dowell SF, Fischer JE, Areerat P, Sornkij D, Jorakate P, Kaewpan A, Prapasiri P, Naorat S, Sangsuk L, Eampokalap B, Moore MR, Carvalho G, Beall B, Ungchusak K, Maloney SA, 2009. Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand. Clin Infect Dis 48 (Suppl 2): S65-S74.
22. Bogaert D, Ha NT, Sluijter M, Lemmens N, De Groot R, Hermans PW, 2002. Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam. J Clin Microbiol 40: 3903-3908. (Pubitemid 35285765)
23. Watanabe H, Asoh N, Hoshino K, Watanabe K, Oishi K, Kositsakulchai W, Sanchai T, Kunsuikmengrai K, Kahintapong S, Khantawa B, Tharavichitkul P, Sirisanthana T, Nagatake T, 2003. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae and molecular characterization of multidrug-resistant serotype 19F, 6B, and 23F pneumococci in northern Thailand. J Clin Microbiol 41: 4178-4183. (Pubitemid 37099683)
24. Srifeungfung S, Chokephaibulkit K, Tribuddharat C, 2007. Serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae isolated from hospitalized patients in Thailand. Southeast Asian J Trop Med Public Health 38: 469-477.
25. Song JH, Lee NY, Ichiyama S, Yoshida R, Hirakata Y, Fu W, Chongthaleong A, Aswapokee N, Chiu CH, Lalitha MK, Thomas K, Perera J, Yee TT, Jamal F, Warsa UC, Vinh BX, Jacobs MR, Appelbaum PC, Pai CH, 1999. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis 28: 1206-1211.
26. Batuwanthudawe R, Karunarathne K, Dassanayake M, de Silva S, Lalitha MK, Thomas K, Steinhoff M, Abeysinghe N, 2009. Surveillance of invasive pneumococcal disease in Colombo, Sri Lanka. Clin Infect Dis 48 (Suppl 2): S136-S140.
27. Xue L, Yao K, Xie G, Zheng Y, Wang C, Shang Y, Wang H, Wan L, Liu L, Li C, Ji W, Xu X, Wang Y, Xu P, Liu Z, Yu S, Yang Y, 2010. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates that cause invasive disease among Chinese children. Clin Infect Dis 50: 741-744.
28. Shah AS, Knoll MD, Sharma PR, Moisi JC, Kulkarni P, Lalitha MK, Steinhoff M, Thomas K, 2009. Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network. Clin Infect Dis 48 (Suppl 2): S123-S128.
29. Phongsamart W, Srifeungfung S, Dejsirilert S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, Chokephaibulkit K, 2007. Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000-2005. Vaccine 25: 1275-1280. (Pubitemid 46027338)
30. Levine OS, Cherian T, Hajjeh R, Knoll MD, 2009. Progress and future challenges in coordinated surveillance and detection of pneumococcal and Hib disease in developing countries. Clin Infect Dis 48 (Suppl 2): S33-S36.
31. Anh DD, Kilgore PE, Slack MP, Nyambat B, Tho le H, Yoshida LM, Nguyen HA, Nguyen CD, Chong CY, Nguyen D, Ariyoshi K, Clemens JD, Jodar L, 2009. Surveillance of pneumococcal-associated disease among hospitalized children in Khanh Hoa Province, Vietnam. Clin Infect Dis 48 (Suppl 2): S57-S64.
32. Pai R, Gertz RE, Beall B, 2006. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44: 124-131. (Pubitemid 43100590)
33. Brito DA, Ramirez M, de Lencastre H, 2003. Serotyping Streptococcus pneumoniae by multiplex PCR. J Clin Microbiol 41: 2378-2384. (Pubitemid 36712439)
34. Saha SK, Darmstadt GL, Baqui AH, Hossain B, Islam M, Foster D, Al-Emran H, Naheed A, Arifeen SE, Luby SP, Santosham M, Crook D, 2008. Identification of serotype in culture negative pneumococcal meningitis using sequential multiplex PCR: implication for surveillance and vaccine design. PLoS One 3: e3576.
35. Hare KM, Smith-Vaughan H, Binks M, Park IH, Nahm MH, Leach AJ, 2009. "Dodgy 6As": differentiating pneumococcal serotype 6C from 6A by use of the Quellung reaction. J Clin Microbiol 47: 1981-1982.
36. Jin P, Xiao M, Kong F, Oftadeh S, Zhou F, Liu C, Gilbert GL, 2009. A simple, accurate serotype-specific PCR assay to differentiate Streptococcus pneumoniae serotypes 6A, 6B and 6C. J Clin Microbiol 47: 2470-2474.
37. Jacobs MR, Bajaksouzian S, Bonomo RA, Good CE, Windau AR, Hujer AM, Massire C, Melton R, Blyn LB, Ecker DJ, Sampath R, 2009. Occurrence, distribution, and origins of Streptococcus pneumoniae serotype 6C, a recently recognized serotype. J Clin Microbiol 47: 64-72.
38. Carvalho Mda G, Pimenta FC, Gertz RE Jr, Joshi HH, Trujillo AA, Keys LE, Findley J, Moura IS, Park IH, Hollingshead SK, Pilishvili T, Whitney CG, Nahm MH, Beall BW, 2009. PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007. J Clin Microbiol 47: 554-559.
39. Weinberger DM, Dagan R, Givon-Lavi N, Regev-Yochay G, Malley R, Lipsitch M, 2008. Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J Infect Dis 197: 1511-1518. (Pubitemid 351706480)